Sign Up Now
Get instant access to over 1 million+ study documents
OR
Already registered? click here to login
By creating your account, you agree to our terms of service, privacy policy and student honor code.
History of Direct to Consumer Advertising of Prescription Drugs in the U.S.
Imagine this: you are at home watching television one evening after work. As you casually flip through the channels searching for something interesting to watch, you notice a multitude of advertisements for prescription drug products. This form of advertisement is known as direct-to-consumer advertising, and is now well-known to practically all American households. One needs only to watch virtually any commercial television program or to browse through any consumer-directed magazine to view advertisements for a variety of prescription drugs. In regard to broadcast media, this is a relatively new phenomenon because, for many years, pharmaceutical manufacturers had to follow certain requirements. These requirements consisted of the inclusion of a substantial amount of material about the drug product's side effects, contraindications, and effectiveness.
Recent changes in 1999 under the guidance of the Food and Drug Administration (FDA) altered the decision making balance between patients and physicians. Historically, prescription drug advertising in the United States was directed primarily at physicians, who were once the sole decision-makers when choosing prescription drugs. As...
The first U.S. prescription drug print advertisement directed to the consumer was issued in 1981 by Boots Pharmaceuticals, for the ibuprofen product. Other drug companies then voluntarily proposed direct to consumer advertisements to FDA. During that time, the FDA and the industry conducted several studies on the effects of these types of advertisements.
In September of 1985, FDA released requirements stating that direct to consumer advertisements must meet the same legal requirements as those directed at physicians. The FDA maintained that pre-existing regulations governing prescription drug advertising would sufficiently safeguard consumers. As a result, pharmaceutical companies began to expand their promotional activities. Historically, the first comprehensive federal legislation regulating food and drugs was the Pure Food and Drugs Act of 1906. This Act was directed toward product labels only and contained no provisions regarding advertising. At the time of its enactment, the labels under which drugs were sold were the primary medium for drug promotions. The Pure Food and Drugs Act defined a product as misbranded only if its label…
Bibliography
Jackson, Charles O. (1970). "Food and Drug Legislation in the New Deal." Princeton University
Press.
Palumbo, Francis B. "The Development of Direct-to-Consumer Prescription Drug Advertising
Regulation." Food and Drug Law Journal 57.3 (2002). 423-443.
http://www.fda.gov/cder/guidance/1804fnl.htm >.
Prescription RX Solutions. 2005. Prescription Rx Solutions. 20 Jan. 2005 < http://www.
Direct to Consumer Advertising According to a report by the United States General Accounting Office, "spending on direct-to-consumer advertising of prescription drugs has tripled in recent years," (Collins et al. p. 4). Consequently, spending on prescription drugs has also risen. Although the United States Food and Drug Administration (FDA) regulates the content of prescription drug advertisements under the Federal Food, Drug, and Cosmetic Act (FFDCA), many critics of direct-to-consumer (DTC) promotion
Direct to Consumer Advertising HISTORY OF DRUG ADVERTISING THE DTC ADVERTISING PHENOMENON CREATING DEMAND DECEPTIVE ADVERTISING - A WOLF IN SHEEP'S CLOTHING CAUSE OF DEATH PROFIT UTILIZATION, PRICING, AND DEMOGRAPHICS LEGISLATION, POLITICS AND PATENTS LEGISLATIVE INITIATIVES REGARDING DTC RECALLED and/or DEADLY DRUGS In order to provide the most efficient method of evaluation, the study will utilize existing stores of qualitative and quantitative data from reliable sources, such as U.S. Government statistical references, University studies, and the studies and publications of non-profit
European pharmaceutical dispensing customs and laws are significantly different than in the U.S. In Germany, for example, one cannot buy vitamins (above a certain small dosage) or aspirin anywhere but a pharmacy. Most drugs we consider OTC are still limited to the pharmacy in many European countries. In considering whether to push for DTC advertising in Europe, American pharmaceutical companies will have to tread carefully, and be mindful of the special
Pharmacy Ethics The author of this report has been asked to review the legal and ethical considerations in play given the test case scenario surrounding Pharmacare and Compcare. As is quickly apparent while reading the case study, the company engaged in a long and extensive list of ethical and/or legal violations as a means to maximize profit and minimize the legal and other red tape that seems to bother them even
Health Advertising Introduction Direct to consumer marketing for healthcare products is a controversial subject because of the fact that it brings together two very different worlds—the free market capitalist world and the health care world—and the end result can be a hodge-podge of confusion in which the best interests of the patient are not always front and center. In a free-market capitalist society, producers want to market their products so that they
organizational studies. While there is focus upon the articles and their contents, the greater focus or endeavor of the paper is to analyze the writing techniques and approaches to research. At the center of the assignment is the relationship among the construction of the research question, the research question, and the research. By studying and referencing the methods of master researchers and writers, the paper forges a path into